The partners will use UNP's AI-based macrocycle discovery platform to develop synthetic peptide therapeutics for multiple ...

Spokane may be hundreds of miles from major academic medical centers, but its becoming a national leader in an advanced ...

Cancer-hunting antibodies coupled with a natural compound found in soil microbes proved a powerful combination against an aggressive type of blood cancer, according to a new study from scientists at ...

Lynozyflic is one of two bispecific antibodies Regeneron hopes will lift its oncology business. Meanwhile, IGM is the latest struggling biotech to agree to a buyout deal from Concentra.

The acquired Seagen products contributed meaningfully to Pfizer’s revenues in 2024 and in the first quarter of 2025. Seagen also has some next-generation ADC candidates in its pipeline.

The addition of Seagen in 2023 also strengthened its position in oncology by adding four ADCs — Adcetris, Padcev, Tukysa and Tivdak. The acquired Seagen products contributed meaningfully to ...

Sakar Healthcare jumped 4.65% to Rs 344.20 after the company announced the receipt of second marketing authorization (MA) of oncology injection (product registration) for the European Union (EU). The ...

DNA-encoded chemical library (DECL) screens are a rapid and economical tool to identify chemical starting points for drug discovery. As a robust transformation for drug discovery, palladium-catalyzed ...

A copper-mediated radiobromination of (hetero)aryl boronic pinacol esters is described. Cyclotron-produced [76/77Br]bromide was isolated using an anion exchange cartridge, wherein the ...

The net result is a positive financial impact, with a projected base-case revenue increase of 11% over five years for a new oncology product utilizing these pathways. Get the details on this revenue ...